Cite
MLA Citation
G. Giordano et al.. “2335 Analysis of activity, efficacy and safety of first line Nab Paclitaxel (Nab-P) and Gemcitabine (G) in advanced pancreatic cancer (APDAC) frail and elderly patients (pts).” European journal of cancer, vol. 51, n.d., pp. S445–. http://access.bl.uk/ark:/81055/vdc_100030628218.0x00002b